Presentation is loading. Please wait.

Presentation is loading. Please wait.

Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis  Wan Ling.

Similar presentations


Presentation on theme: "Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis  Wan Ling."— Presentation transcript:

1 Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis  Wan Ling Wong, MBiostat, Xinyi Su, MD, Xiang Li, BSc, Chui Ming G Cheung, MD, Ronald Klein, MD, Dr Ching-Yu Cheng, MD, Prof Tien Yin Wong, MBBS  The Lancet Global Health  Volume 2, Issue 2, Pages e106-e116 (February 2014) DOI: /S X(13) Copyright © 2014 Wong et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions

2 Figure 1 Overall and race-specified pooled prevalence of early age-related macular degeneration (AMD) Dashed line refers to the overall pooled prevalence estimate presented in bold. See appendix (p 7, 8) for study references. The Lancet Global Health 2014 2, e106-e116DOI: ( /S X(13) ) Copyright © 2014 Wong et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions

3 Figure 2 Overall and race-specified pooled prevalence of late age-related macular degeneration Dashed line refers to the overall pooled prevalence estimate presented in bold. The Lancet Global Health 2014 2, e106-e116DOI: ( /S X(13) ) Copyright © 2014 Wong et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions

4 Figure 3 Overall and race-specified pooled prevalence of any age-related macular degeneration Dashed line refers to the overall pooled prevalence estimate presented in bold. The Lancet Global Health 2014 2, e106-e116DOI: ( /S X(13) ) Copyright © 2014 Wong et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions

5 Figure 4 Prevalence of age-related macular degeneration (AMD) by ethnic group (A) and (B) geographical region Error bars=95% CrI. The Lancet Global Health 2014 2, e106-e116DOI: ( /S X(13) ) Copyright © 2014 Wong et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions

6 Figure 5 Age trends of prevalence of age-related macular degeneration (AMD) by ethnicity (A and B) and region (C and D) The Lancet Global Health 2014 2, e106-e116DOI: ( /S X(13) ) Copyright © 2014 Wong et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions

7 Figure 6 Projection of number of people with early and late age-related macular degeneration (AMD) by regions in 2014, 2020, and 2040 The Lancet Global Health 2014 2, e106-e116DOI: ( /S X(13) ) Copyright © 2014 Wong et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions

8 The Lancet Global Health 2014 2, e106-e116DOI: (10
The Lancet Global Health 2014 2, e106-e116DOI: ( /S X(13) ) Copyright © 2014 Wong et al. Open Access article distributed under the terms of CC BY-NC-ND Terms and Conditions


Download ppt "Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis  Wan Ling."

Similar presentations


Ads by Google